Coagulation and Fibrinolysis in Normal Pregnancy and Complicated Pregnancy
- 1The Department of Laboratory Medicine Peking University Third Hospital Beijing China
- 2The Department of Psychiatry Peking University Sixth Hospital Beijing China
- 3The State Key Laboratory of Vascular Homeostasis and Remodeling Peking University Third Hospital Beijing China
Abstract
Introduction: Pregnancy induces significant physiological changes in the hemostatic system, leading to a hypercoagulable state to prevent postpartum hemorrhage. These adaptations involve alterations in coagulation and fibrinolysis, which can be further modified in complicated pregnancies such as gestational diabetes mellitus (GDM) and preeclampsia (PE).
Aim: This study investigated coagulation and fibrinolysis parameters in healthy pregnancies across different gestational stages and compared them to GDM and PE in the third trimester.
Methods: In this retrospective study, 293 pregnant women undergoing prenatal check‐ups were enrolled. Coagulation parameters (prothrombin time, PT; activated partial thromboplastin time, APTT; thrombin time, TT; and fibrinogen, FIB) and fibrinolysis parameters (fibrin/fibrinogen degradation products, FDP; D‐dimer; plasminogen activator inhibitor‐1, PAI‐1; tissue plasminogen activator, tPA; and plasmin‐α2‐plasmin inhibitor complex, PIC) were measured and compared across groups: non‐pregnant controls, healthy pregnancies (first trimester, third trimester, delivery), GDM, and PE.
Results: In normal pregnancy, all gestational stages showed significantly shortened PT, APTT, and TT and elevated FIB, FDP, D‐dimer, PAI‐1, and tPA compared to non‐pregnant controls. FDP and D‐dimer increased progressively with gestation. Compared to the third trimester, GDM was characterized by significantly higher PAI‐1 and tPA but lower PIC, whereas PE was characterized by significantly higher PAI‐1 and PIC, prolonged APTT, and lower tPA. Furthermore, among healthy women at delivery and those with GDM, overweight and obesity were associated with significantly increased PAI‐1 levels.
Conclusion: As pregnancy progresses, enhanced coagulation with hypofibrinolysis occurs in normal pregnancy, and further hypofibrinolysis is the primary thrombotic driver in GDM and obesity. PE presents a more complex alteration in both coagulation and fibrinolytic pathways.
Related
- ANXA2 as a Candidate Molecular Hub Linking Fibrinolysis, Coagulation, and Immune Remodeling in Hepatocellular Carcinoma: An Integrative Multi-Omics Analysis
- Coagulation and fibrinolysis biomarkers associated with gastrointestinal bleeding in children with immunoglobulin A vasculitis: a retrospective cohort study.
- CO070 | PLASMIN GENERATION AND ITS INTERPLAY WITH COAGULATION AND FIBRINOLYSIS IN ATRIAL FIBRILLATION: IMPACT OF ANTICOAGULANT THERAPY
- Pregnancy Complicated by Citrin Deficiency and Gestational Diabetes Mellitus: Perioperative Metabolic Management and Postoperative Analgesic Challenges Following Caesarean Delivery
- Pregnancy-Induced Hypertension Complicated by Posterior Reversible Encephalopathy Syndrome: A Case Series of Two Patients.
BibTeX
@article{su2026coagulation,
title = {{Coagulation and Fibrinolysis in Normal Pregnancy and Complicated Pregnancy}},
author = {Yang Su and Yao Wei and Cheng Liu and Yafei Gao and Xiaolong Ma and Yongxin Li and Rui Qiao},
journal = {International Journal of Laboratory Hematology},
year = {2026},
month = jul,
doi = {10.1111/ijlh.70207},
url = {https://doi.org/10.1111/ijlh.70207},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Coagulation and Fibrinolysis in Normal Pregnancy and Complicated Pregnancy
AU - Yang Su
AU - Yao Wei
AU - Cheng Liu
AU - Yafei Gao
AU - Xiaolong Ma
AU - Yongxin Li
AU - Rui Qiao
PY - 2026
DA - 2026/07/27
JO - International Journal of Laboratory Hematology
DO - 10.1111/ijlh.70207
UR - https://doi.org/10.1111/ijlh.70207
AB - Introduction: Pregnancy induces significant physiological changes in the hemostatic system, leading to a hypercoagulable state to prevent postpartum hemorrhage. These adaptations involve alterations in coagulation and fibrinolysis, which can be further modified in complicated pregnancies such as gestational diabetes mellitus (GDM) and preeclampsia (PE). Aim: This study investigated coagulation and fibrinolysis parameters in healthy pregnancies across different gestational stages and compared them to GDM and PE in the third trimester. Methods: In this retrospective study, 293 pregnant women undergoing prenatal check‐ups were enrolled. Coagulation parameters (prothrombin time, PT; activated partial thromboplastin time, APTT; thrombin time, TT; and fibrinogen, FIB) and fibrinolysis parameters (fibrin/fibrinogen degradation products, FDP; D‐dimer; plasminogen activator inhibitor‐1, PAI‐1; tissue plasminogen activator, tPA; and plasmin‐α2‐plasmin inhibitor complex, PIC) were measured and compared across groups: non‐pregnant controls, healthy pregnancies (first trimester, third trimester, delivery), GDM, and PE. Results: In normal pregnancy, all gestational stages showed significantly shortened PT, APTT, and TT and elevated FIB, FDP, D‐dimer, PAI‐1, and tPA compared to non‐pregnant controls. FDP and D‐dimer increased progressively with gestation. Compared to the third trimester, GDM was characterized by significantly higher PAI‐1 and tPA but lower PIC, whereas PE was characterized by significantly higher PAI‐1 and PIC, prolonged APTT, and lower tPA. Furthermore, among healthy women at delivery and those with GDM, overweight and obesity were associated with significantly increased PAI‐1 levels. Conclusion: As pregnancy progresses, enhanced coagulation with hypofibrinolysis occurs in normal pregnancy, and further hypofibrinolysis is the primary thrombotic driver in GDM and obesity. PE presents a more complex alteration in both coagulation and fibrinolytic pathways.
SN - 1751-5521
SN - 1751-553X
ER -